U.S. Emerging Insulin Delivery Technologies Markets
Published on: 23-Apr-2004 | SKU: HC00957-NA-MR_04812

Need more details?
$3,950.00
DownloadLink
Need more details?

This report analyzes the U.S. emerging insulin delivery technologies market, for the forecast period 2000 to 2010. The report is segmented into 6 chapters viz Executive Summary, Total Market, Injectable Insulin, Insulin Pumps, Inhalable Insulin, Oral Insulin and Other Emerging Technologies. Each segment provides revenue forecasts, market share,pricing trends,demand analysis,competitive structure and market and technology trends. Drivers, restraints and challenges and the strategic recommendations are also discussed.The Frost & Sullivan Awards are conferred on deserving companies.

Executive Summary

  • Executive Summary

Report Scope & Segmentation

  • Scope and Methodology
  • Market Segmentation

Market Overview

  • Introduction
  • Market Engineering Measurements
  • Challenges

Market Demand & Forecasts

  • Demand Analysis
  • Patient Forecasts
  • Revenue Forecasts

Competitive Analysis

  • Competitive Structure
  • Pipeline Analysis
  • Total Market Share

Mergers and Acquisitions

  • Disetronic and Roche Diagnostics
  • Equidyne Becomes Injex
  • Generex and Eli Lilly Dissolve Partnership
  • Eli Lilly and BD Partners

Frost & Sullivan Awards

  • Technology Excellence Award
  • Growth Strategy Award
  • Patient Compliance Enhancement Strategy Award

Segment Highlights

Insulin Syringes Market

Insulin Pens Market

Jet Injectors Market

Segment Highlights

Overview

Competitive Analysis

Segment Highlights

Overview

Product and Technology Analysis

Segment Highlights

Oral Insulin Market

Other Emerging Insulin Delivery Technologies

Decision Support Database


Have questions about this research or need deeper insights?
Speak directly with our analytics experts for tailored recommendations.
Purchase includes:
  • Report download
  • Growth Dialog™ with our experts

Growth Dialog™

A tailored session with you where we identify the:
  • Strategic Imperatives
  • Growth Opportunities
  • Best Practices
  • Companies to Action

Impacting your company's future growth potential.

This report analyzes the U.S. emerging insulin delivery technologies market, for the forecast period 2000 to 2010. The report is segmented into 6 chapters viz Executive Summary, Total Market, Injectable Insulin, Insulin Pumps, Inhalable Insulin, Oral Insulin and Other Emerging Technologies. Each segment provides revenue forecasts, market share,pricing trends,demand analysis,competitive structure and market and technology trends. Drivers, restraints and challenges and the strategic recommendations are also discussed.The Frost & Sullivan Awards are conferred on deserving companies.
More Information
Deliverable Type Market Research
No Index Yes
Podcast No
Industries Healthcare
WIP Number A742-01-00-00-00
Is Prebook No

U.S. Emerging Insulin Delivery Technologies Markets

HealthcareU.S. Emerging Insulin Delivery Technologies Markets

 

RELEASE DATE
23-Apr-2004
REGION
North America
Deliverable Type
Market Research
Research Code: A742-01-00-00-00
SKU: HC00957-NA-MR_04812
AvailableYesPDF Download
$3,950.00
In stock
SKU
HC00957-NA-MR_04812